Cannabis stocks spike on reports Trump plans to ease federal pot restrictions

Impact · against what's priced in

Reports of potential rescheduling to Schedule III act as a significant catalyst for cannabis stocks, though the lack of final White House confirmation maintains a high risk of reversal. The immediate price surges reflect the market pricing in the removal of 280E tax burdens and improved capital access, though full legalization remains a distant congressional hurdle.

CGC+0.80

No priced-in read yet